Kezar Life Sciences Inc.

6.29
-0.11 (-1.72%)
Jan 23, 2025, 2:53 PM - Market open

Kezar Life Sciences Statistics

Share Statistics

Kezar Life Sciences has 7.30M shares outstanding. The number of shares has increased by -89.98% in one year.

Shares Outstanding 7.30M
Shares Change (YoY) n/a
Shares Change (QoQ) -90%
Owned by Institutions (%) n/a
Shares Floating 6.22M
Failed to Deliver (FTD) Shares 1
FTD / Avg. Volume 0%

Short Selling Information

The latest short interest is 177.96K, so 2.44% of the outstanding shares have been sold short.

Short Interest 177.96K
Short % of Shares Out 2.44%
Short % of Float 2.87%
Short Ratio (days to cover) 0.93

Valuation Ratios

The PE ratio is -6.74 and the forward PE ratio is -0.72.

PE Ratio -6.74
Forward PE -0.72
PS Ratio 98.15
Forward PS 6.7
PB Ratio 3.66
P/FCF Ratio -8.23
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Kezar Life Sciences Inc. has an Enterprise Value (EV) of 87.67M.

EV / Earnings -0.86
EV / Sales 12.52
EV / EBITDA -0.88
EV / EBIT -0.83
EV / FCF -1.05

Financial Position

The company has a current ratio of 11.66, with a Debt / Equity ratio of 0.1.

Current Ratio 11.66
Quick Ratio 11.66
Debt / Equity 0.1
Total Debt / Capitalization 9.17
Cash Flow / Debt -4.31
Interest Coverage -67.89

Financial Efficiency

Return on equity (ROE) is -0.54% and return on capital (ROIC) is -50.96%.

Return on Equity (ROE) -0.54%
Return on Assets (ROA) -0.46%
Return on Capital (ROIC) -50.96%
Revenue Per Employee 120.69K
Profits Per Employee -1.76M
Employee Count 58
Asset Turnover 0.03
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -20.37% in the last 52 weeks. The beta is 0.22, so Kezar Life Sciences 's price volatility has been higher than the market average.

Beta 0.22
52-Week Price Change -20.37%
50-Day Moving Average 6.91
200-Day Moving Average 14.64
Relative Strength Index (RSI) 33.96
Average Volume (20 Days) 58.12K

Income Statement

In the last 12 months, Kezar Life Sciences had revenue of 7.00M and earned -101.87M in profits. Earnings per share was -1.4.

Revenue 7.00M
Gross Profit 5.93M
Operating Income -105.24M
Net Income -101.87M
EBITDA -99.25M
EBIT -105.24M
Earnings Per Share (EPS) -1.4
Full Income Statement

Balance Sheet

The company has 35.49M in cash and 18.93M in debt, giving a net cash position of 16.56M.

Cash & Cash Equivalents 35.49M
Total Debt 18.93M
Net Cash 16.56M
Retained Earnings -350.76M
Total Assets 164.09M
Working Capital 135.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -81.64M and capital expenditures -1.81M, giving a free cash flow of -83.45M.

Operating Cash Flow -81.64M
Capital Expenditures -1.81M
Free Cash Flow -83.45M
FCF Per Share -1.15
Full Cash Flow Statement

Margins

Gross margin is 84.77%, with operating and profit margins of -1.50K% and -1.46K%.

Gross Margin 84.77%
Operating Margin -1.50K%
Pretax Margin -1.46K%
Profit Margin -1.46K%
EBITDA Margin -1.42K%
EBIT Margin -1.50K%
FCF Margin -1.19K%

Dividends & Yields

KZR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -21.84%
FCF Yield -178.35%
Dividend Details

Analyst Forecast

The average price target for KZR is $9, which is 40.4% higher than the current price. The consensus rating is "Hold".

Price Target $9
Price Target Difference 40.4%
Analyst Consensus Hold
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Oct 30, 2024. It was a backward split with a ratio of 1:10.

Last Split Date Oct 30, 2024
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -3.61
Piotroski F-Score 2